Isavuconazole is a once-daily antifungal, used to treat a wide array of fungal infections. In this touchINFECTIOUS DISEASES interview, we met with Prof. Kayla Stover Hielscher (University of Mississippi School of Pharmacy, Jackson, MS, USA) to discuss isavuconazole’s properties and the efficacy and safety compared to other treatment options.
The abstract entitled: ‘This Drug for That Bug: Really? An Evidence-Based Discussion of Antimicrobial Activity Relevant to Antimicrobial Stewardship‘ was presented at IDWeek 2022, 19-23 October 2022.
Interviews available in this series:
Ceftriaxone as a treatment option for MSSA, ensuring optimum activity
Linezolid as a treatment option for MRSA bacteraemia
Questions:
- What properties of isavuconazole make it a good treatment choice for Candida species? (0:21)
- What does the literature tell us about its efficacy and safety compared to other azoles? (0:50)
Disclosures: Kayla Stover Hielscher has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
